Plants are biological factories that run on sunlight and water
As humanity reaches toward Mars, a quiet biological insight may reshape how we think about medicine itself: that healing compounds need not be manufactured in distant factories, but grown in living plants wherever light and water exist. Researchers at UC San Diego have developed a way to coax therapeutic molecules from intact plants under space-like conditions, offering a potential answer to one of deep-space travel's most overlooked vulnerabilities — the expiration of the medicine cabinet. The work, rooted in a decade of studying a plant virus with surprising cancer-fighting properties, suggests that the future of pharmaceuticals may be less industrial and more botanical, whether aboard a spacecraft bound for Mars or in a resource-limited community far from the nearest hospital.
- Astronauts on Mars-bound missions face a silent crisis: more than half of all medications stored in space lose their potency before a round trip could even be completed.
- Resupply from Earth is not a solution at interplanetary distances, forcing researchers to ask whether medicine could be grown rather than packed and shipped.
- The key breakthrough was learning to harvest therapeutic compounds from living plants without destroying them — a vacuum-and-centrifuge technique that leaves leaves intact for repeated use.
- Simulated microgravity and space radiation not only failed to stop the process but in some cases increased the yield, suggesting space stress may actually work in the method's favor.
- The team is now preparing for real mission trials and exploring how the same low-infrastructure approach could bring complex medicines to resource-limited regions on Earth.
Astronauts heading to Mars carry a problem no engineer has yet solved: their medicines expire. More than half the drugs aboard the International Space Station lose potency within three years — barely enough time for a round trip to the red planet. Resupply from Earth becomes impossible once a crew is millions of miles away. Researchers at UC San Diego's Jacobs School of Engineering asked a different question: what if astronauts could grow their medicine instead?
At the center of the work is cowpea mosaic virus, a plant pathogen that Nicole Steinmetz's team has studied for over a decade. In preclinical and clinical trials, the virus proved capable of triggering immune responses that attacked tumor cells — a promising cancer treatment, but one that normally requires industrial-scale manufacturing. Plants, Steinmetz recognized, are already doing this biological work. They need only light, water, and soil, and they're already being cultivated in space.
The harder problem was extraction. Traditional methods grind harvested leaves into a slurry and run it through room-sized lab equipment — impractical aboard any spacecraft. Postdoctoral researcher Patrick Opdensteinen led the team toward a more elegant solution: coaxing the viral particles into the apoplast, a network of tiny spaces just outside plant cell membranes, then drawing them out with vacuum pressure and a centrifuge. The leaves survive the process intact, allowing the same plant to be harvested again and again. More than 50 plants were processed in under two hours.
To test the method under space-like conditions, the team built a rotating machine that simulates microgravity and exposed plants to temperature swings and oxidative stress mimicking space radiation. Some stressors actually increased therapeutic yield — stressed plants appear more susceptible to viral infection, which in this case is precisely the point.
Published in npj Science of Plants in June 2026, the findings open two futures: a living pharmacy aboard long-duration spacecraft, and a low-infrastructure production method for medicine in resource-limited regions on Earth. Work continues on how space conditions affect plant nutrition and how the violence of launch affects seeds and genetic materials. The destination is coming into focus — medicine that doesn't need a factory, only a plant.
Astronauts heading to Mars face a problem that no amount of engineering can fully solve: their medicine cabinet expires. More than half the medications stored aboard the International Space Station lose potency within three years—barely enough time for a round trip to the red planet, which takes roughly 200 days each way. Resupply missions from Earth become impractical once you're millions of miles away. So researchers at UC San Diego asked a different question: what if astronauts didn't need to bring their medicines at all? What if they could grow them?
Nicole Steinmetz and her team at the Jacobs School of Engineering have spent more than a decade studying cowpea mosaic virus—a plant pathogen that, counterintuitively, shows remarkable promise as a cancer treatment. In preclinical studies with mice and in clinical trials with dogs, the virus triggered immune responses that attacked tumor cells. The compound is complex, the kind of thing that normally requires massive sterile tanks and industrial infrastructure to manufacture. But plants, Steinmetz realized, are already doing this work. They're biological factories that need only light, water, and soil. They're already being grown in space. And they recycle air and water as a bonus.
The real challenge wasn't growing the plants or even producing the therapeutic compound inside them. It was getting the medicine out without destroying the plant in the process. The traditional method—harvesting leaves, grinding them into what one researcher described as a smoothie, then running that slurry through lab equipment that fills an entire room—won't work on a spacecraft. So Steinmetz's team, led by postdoctoral researcher Patrick Opdensteinen, borrowed a trick from how pharmaceutical companies extract products from bacteria and mammalian cells: they let the plants secrete the compound themselves.
Inside plant leaves exists a network of tiny spaces called the apoplast, located just outside the cell membrane. The researchers discovered they could coax the cowpea mosaic virus particles into this compartment, then extract them without harming the plant. The process is elegant in its simplicity. Submerge the leaves in a buffer solution inside a sealed vessel. Apply vacuum, which floods the apoplast with fluid. Spin the saturated leaves in a centrifuge to draw the liquid back out. Filter the result to separate the viral particles from unwanted plant material. Because the leaves remain intact, the same plant can be harvested repeatedly. The team demonstrated the method on more than 50 plants in under two hours.
To test whether this would work in actual space conditions, Steinmetz collaborated with Maziar Ghazinejad, a colleague in mechanical and aerospace engineering. They built a random positioning machine—equipment normally used to study how materials behave in microgravity—and adapted it to rotate plants continuously, effectively canceling out gravity's effects. They exposed the plants to temperature swings and oxidative stress to simulate space radiation. In some cases, these stressors actually increased the yield of therapeutic compound. Opdensteinen hypothesized that stressed plants become more susceptible to viral infection, and since the product itself is derived from a plant virus, that vulnerability becomes an advantage.
The findings, published in npj Science of Plants in early June 2026, point toward two futures. One is immediate: astronauts on long missions could maintain a living pharmacy aboard their spacecraft, growing fresh doses of medicine on demand without the weight and storage constraints of pre-packaged drugs. The other is earthbound. Resource-limited regions without access to expensive pharmaceutical infrastructure could use the same method to produce complex medicines locally, using only plants, light, and water. Before either vision becomes reality, the team has more work ahead. They're studying how space conditions affect water and nutrient uptake in plants. They're partnering with UC San Diego's Rocket Propulsion Laboratory to understand how the violence of launch affects plant seeds and the genetic materials used in the process. But the path forward is clearer now. Medicine, it turns out, doesn't have to be manufactured in a factory. It can be grown.
Notable Quotes
With plants, you can grow complex therapeutic compounds using light, water and soil— Nicole Steinmetz, UC San Diego
You end up with something that looks like a smoothie, and you can imagine getting your product out of that smoothie is challenging— Patrick Opdensteinen, postdoctoral researcher
The Hearth Conversation Another angle on the story
Why does medication degrade faster in space? Is it the radiation, or something about the environment itself?
It's the whole package—radiation, temperature swings, the lack of atmospheric protection. But the real problem for long missions isn't just degradation. It's that you can't resupply. You leave Earth with what you have, and if half of it expires in three years, you're in trouble on a Mars mission.
So why plants? Why not just engineer a synthetic compound that's more stable?
You could try, but plants are already doing the hard work. They're biological factories that run on sunlight and water. They're already being cultivated in space for food and air recycling. Why build something new when you can use what's already there?
The extraction process sounds almost too simple—vacuum, centrifuge, filter. Why hasn't this been done before?
Because nobody needed it before. Pharmaceutical companies have labs full of equipment because they're processing thousands of plants at scale. But on a spacecraft, you don't have room for a lab. You need something that fits in a corner and takes two hours to process 50 plants. That constraint forced them to think differently.
What happens to the plant after you extract the virus? Can you really harvest it multiple times?
Yes. The leaves stay intact. The virus is secreted into spaces just outside the cell membrane, so you're drawing it out without damaging the tissue. In theory, you could harvest the same plant dozens of times. That's what makes it scalable.
The stress actually increased yields. That seems backwards.
It does, until you remember that the product is a plant virus. Stressed plants become more susceptible to infection. So the radiation and temperature swings that would normally be problems become useful. The plant's own vulnerability becomes the tool.
When do they actually test this in space?
That's the next phase. They've tested it under simulated conditions—the rotating machine, the radiation exposure. But they still need to understand how real microgravity affects water movement in plants, how launch affects the seeds. They're working with the Rocket Propulsion Laboratory on that now. Real space trials are coming, but not yet.